Scythian Biosciences (TSXV:SCYB) has made its first strategic purchase, the company announced on Monday (July 30). following the sale of its Latin American assets to a major Canadian cannabis licensed producer (LP). The company also revealed a listing change for its stock.

On July 17 Scythian announced a transaction with Aphria (TSX:APH) for all of its interests across the Latin American cannabis market for a price tag of C$193 million in Aphria shares paid to Scythian.


The TSX Venture-listed (TSXV) cannabis company is now eyeing an entry into the Florida market with the purchase of CannCure Investments, a Canadian company currently working on the acquisition of a stake in 3 Boys Farms, a licensed producer in the state.

Rob Reid, Scythian’s CEO, said Florida is becoming one of the “largest and fastest growing medical cannabis markets” in the US.

The prized acquisition of 3 Boys Farms includes its 40,000 square feet of greenhouses for cannabis cultivation and its licenses for retail shops. According to Scythian, the Florida producer is in the process of securing locations across the state.

Scythian drops TSXV to pursue US asset

Due to the potential entry of the US cannabis market, Scythian revealed to investors it will stop offering its stock on the TSXV and will now list on the Canadian Securities Exchange (CSE), an exchange that allows listings to hold assets in the federally illegal market.

The company told investors it expects the exchange transition will be done within the next 10 business days. Currently Scythian’s share trading is halted.

The entire deal, which also includes the acquisition of an undisclosed medical healthcare organization in Florida, consist of a package payment Scythian will initially purchase a 70 percent stake in CannCure and obtain the option for the remaining 30 percent at the same valuation.

According to the company the transaction consists of a C$93.3 million in equity from Scythian common shares, with the addition of a C$43.2 million cash investment into the company.

In order for the Scythian-CannCure transaction to complete, the investment company must close its initial 60 percent stake acquisition of 3 Boys Farms before August 31.

Scythian is also requiring CannCure to hold an option to acquire the balance of the issued and outstanding shares before the end of 2018.

Investor takeaway

Following the dump of its Latin American assets to Aphria, Scythian has elected to seek a stake in the US market which will lead it to swap public exchanges.

Florida has proved to be a worthwhile market for public cannabis operators and a tentative upcoming vote on the legalization of cannabis for adult-use could provide an even higher boost to the assets in the state.

The last available share price for Scythian was C$3.49 on July 25.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less